Last update 01 Nov 2024
MQ-710
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Gene therapy |
Synonyms |
Target |
Mechanism Flt3L modulators(Fms-related tyrosine kinase 3 ligand modulators), OX40L modulators(Tumor necrosis factor ligand superfamily member 4 modulators), Gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization  Imvaq Therapeutics Corp.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with MQ-710A First-In-Human Phase I, Open Label, Safety and Tolerability Study of Escalating Multiple Doses of Intratumoral MQ710, a Multi-Transgene Expressing Modified Vaccinia Virus Ankara-Based Virotherapy, Alone and in Combination With the Systemic Checkpoint Inhibitor Pembrolizumab in Solid Tumors
100 Clinical Results associated with MQ-710
Login to view more data
100 Translational Medicine associated with MQ-710
Login to view more data
100 Patents (Medical) associated with MQ-710
Login to view more data
100 Deals associated with MQ-710
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 1 | US | 04 May 2023 | |
| Basal Cell Carcinoma | Phase 1 | US | 04 May 2023 | |
| Cutaneous Squamous Cell Carcinoma | Phase 1 | US | 04 May 2023 | |
| Extramammary Paget Disease | Phase 1 | US | 04 May 2023 | |
| Kaposi Sarcoma | Phase 1 | US | 04 May 2023 | |
| Melanoma | Phase 1 | US | 04 May 2023 | |
| Merkel Cell Carcinoma | Phase 1 | US | 04 May 2023 | |
| Refractory Cancer | Phase 1 | US | 04 May 2023 | |
| Skin Appendage Carcinoma | Phase 1 | US | 04 May 2023 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 1 | US | 04 May 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free